4-butyrolactone has been researched along with Staphylococcal Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arp, J; Bardl, B; Brakhage, AA; Brock, DA; García-Altares, M; Götze, S; Klapper, M; Mattern, DJ; Mukherji, R; Peschel, G; Queller, DC; Stallforth, P; Strassmann, JE; Willing, K | 1 |
| Chen, M; Liu, M; She, ZG; Wang, CY; Wang, KL | 1 |
2 other study(ies) available for 4-butyrolactone and Staphylococcal Infections
| Article | Year |
|---|---|
Synergistic activity of cosecreted natural products from amoebae-associated bacteria.
Topics: 4-Butyrolactone; Anti-Bacterial Agents; Bacterial Proteins; Biological Products; Dictyostelium; Drug Synergism; Genome, Bacterial; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Pseudomonas; Quorum Sensing; Staphylococcal Infections | 2018 |
Bioactive steroid derivatives and butyrolactone derivatives from a gorgonian-derived Aspergillus sp. fungus.
Topics: 4-Butyrolactone; Animals; Anti-Bacterial Agents; Aspergillus; Biofouling; Humans; Larva; Microbial Sensitivity Tests; Models, Molecular; Staphylococcal Infections; Staphylococcus aureus; Steroids; Thoracica | 2015 |